Science Explorer Back to mapMap
Discussion
Company · Lund · Sweden

Active Biotech (Sweden)

activebiotech.comROR OpenAlex
World rank, all time
#33,665
of 34,923
Rank in Sweden
#253
of 259
Research works
176
▲ 23% vs 2018-21
Citations
5.7k
32.4 per fractional work
Top-10% rate
7.3%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
28%
world 40%
International
34%
world 18%
Active Biotech (Sweden)

Which fields of science does Active Biotech (Sweden) work in?

In all years, 48% of research at Active Biotech (Sweden) is in Life Sciences, 31% in Health Sciences. Its largest fields are Medicine (29%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (18%). It does 3.0× the world's share of Life Sciences.

Life Sciences: 85 fractional works · 48.2% of its workBiochemistry, Genetics and Molecular Biology: 42 fractional works · 23.9% of its workMolecular Biology: 31 fractional works · 17.4% of its workCancer Research: 3 fractional works · 1.6% of its workGenetics: 3 fractional works · 1.6% of its workBiotechnology: 3 fractional works · 1.5% of its workCell Biology: 2 fractional works · 0.9% of its workClinical Biochemistry: 1 fractional works · 0.3% of its workEndocrinology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workImmunology and Microbiology: 32 fractional works · 18.3% of its workImmunology: 31 fractional works · 17.7% of its workMicrobiology: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 6 fractional works · 3.6% of its workPlant Science: 2 fractional works · 0.9% of its workFood Science: 1 fractional works · 0.8% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 0.7% of its workAnimal Science and Zoology: 1 fractional works · 0.6% of its workInsect Science: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 1.7% of its workPharmacology: 3 fractional works · 1.4% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 54 fractional works · 30.7% of its workMedicine: 51 fractional works · 29.0% of its workOncology: 13 fractional works · 7.5% of its workRadiology, Nuclear Medicine and Imaging: 9 fractional works · 5.0% of its workPulmonary and Respiratory Medicine: 5 fractional works · 2.6% of its workPharmacology: 3 fractional works · 1.7% of its workHematology: 3 fractional works · 1.5% of its workInfectious Diseases: 2 fractional works · 1.3% of its workEpidemiology: 2 fractional works · 1.2% of its workSurgery: 2 fractional works · 1.1% of its workRheumatology: 1 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.8% of its workPhysiology: 1 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.6% of its workImmunology and Allergy: 1 fractional works · 0.5% of its workGenetics: 1 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.5% of its workBiochemistry: 1 fractional works · 0.5% of its workNeurology: 1 fractional works · 0.4% of its workPathology and Forensic Medicine: 1 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.1% of its workNursing: 2 fractional works · 0.9% of its workNutrition and Dietetics: 2 fractional works · 0.9% of its workHealth Professions: 1 fractional works · 0.5% of its workGeneral Health Professions: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workPhysical Sciences: 36 fractional works · 20.6% of its workChemistry: 17 fractional works · 9.6% of its workOrganic Chemistry: 8 fractional works · 4.5% of its workSpectroscopy: 6 fractional works · 3.3% of its workAnalytical Chemistry: 2 fractional works · 1.3% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 10 fractional works · 5.7% of its workBiomedical Engineering: 7 fractional works · 3.7% of its workMechanical Engineering: 1 fractional works · 0.6% of its workMechanics of Materials: 1 fractional works · 0.6% of its workElectrical and Electronic Engineering: 1 fractional works · 0.3% of its workControl and Systems Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEnvironmental Science: 4 fractional works · 2.2% of its workEcology: 2 fractional works · 1.1% of its workWater Science and Technology: 2 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMaterials Science: 4 fractional works · 2.1% of its workBiomaterials: 2 fractional works · 0.9% of its workPolymers and Plastics: 1 fractional works · 0.6% of its workMaterials Chemistry: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemical Engineering: 1 fractional works · 0.5% of its workBioengineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.0% of its workEnergy: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 0.5% of its workSocial Sciences: 1 fractional works · 0.3% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workArts and Humanities: 0 fractional works · 0.2% of its workALL ITS WORKActive Biotech(Sweden)176fractional works, all years
Life Sciences48%Physical Sciences21%Health Sciences31%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4223.9%
    2. Immunology and Microbiology3218.3%
    3. Agricultural and Biological Sciences63.6%
    4. Pharmacology, Toxicology and Pharmaceutics31.7%
    5. Neuroscience10.6%
    1. Medicine5129.0%
    2. Nursing20.9%
    3. Health Professions10.5%
    4. Dentistry00.2%
    5. Veterinary00.1%
    1. Chemistry179.6%
    2. Engineering105.7%
    3. Environmental Science42.2%
    4. Materials Science42.1%
    5. Chemical Engineering10.5%
    6. Physics and Astronomy00.2%
    7. Earth and Planetary Sciences00.1%
    8. Computer Science00.0%
    9. Energy00.0%
    1. Social Sciences10.3%
    2. Arts and Humanities00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.26× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.01× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 14.13× its world share, 3 worksImmunology and Micro…Neuroscience: 0.20× its world share, 0 worksNeuroscienceChemistry: 2.41× its world share, 1 worksChemistryEngineering: 0.49× its world share, 1 worksEngineeringMaterials Science: 2.19× its world share, 2 worksMaterials ScienceDentistry: 3.54× its world share, 0 worksDentistryHealth Professions: 0.19× its world share, 0 worksHealth ProfessionsMedicine: 1.80× its world share, 7 worksMedicineSocial Sciences: 0.20× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.1×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology14.13×3 works
  2. Biochemistry, Genetics and Molecular Biology4.01×4 works
  3. Dentistry3.54×0 works
  4. Chemistry2.41×1 works
  5. Materials Science2.19×2 works
  6. Medicine1.80×7 works
  7. Agricultural and Biological Sciences1.26×1 works
  8. Engineering0.49×1 works
  9. Neuroscience0.20×0 works
  10. Social Sciences0.20×0 works
  11. Health Professions0.19×0 works

Who are the top researchers at Active Biotech (Sweden)?

Ranked on the quality score, Helén Tuvesson, Helena Eriksson and Örjan Nordle lead among researchers whose main affiliation is Active Biotech (Sweden).

  1. 1 Helén Tuvesson Sweden · #1,568,527 worldwide 523 citations · 21 works
  2. 2 Helena Eriksson Sweden · #1,720,060 worldwide 846 citations · 73 works
  3. 3 Örjan Nordle Sweden · #2,120,199 worldwide 1.5k citations · 50 works
  4. 4 Poul Sørensen Sweden · #2,893,976 worldwide 655 citations · 19 works
  5. 5 Per Björk Sweden · #3,711,062 worldwide 2.2k citations · 80 works
  6. 6 Göran Forsberg Sweden · #4,371,092 worldwide 2.7k citations · 108 works
  7. 7 Marie Törngren Sweden · #5,556,521 worldwide 463 citations · 77 works
  8. 8 Leif Svensson Sweden · #5,693,062 worldwide 199 citations · 31 works
  9. 9 P. O. Gunnarsson Sweden · #5,751,806 worldwide 425 citations · 25 works
All ranked researchers at Active Biotech (Sweden)

What are the most cited papers from Active Biotech (Sweden)?

The most cited paper from Active Biotech (Sweden) is "The Interaction Properties of Costimulatory Molecules Revisited" (Alison V. Collins, Douglas W. Brodie, Robert J.C. Gilbert et al., 2002), with 689 citations. Next come "Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy" (464) and "Clinical utility of cytokeratins as tumor markers" (386).

Most cited papers
#PaperReleasedCitations
1 The Interaction Properties of Costimulatory Molecules Revisited Alison V. Collins, Douglas W. Brodie, Robert J.C. Gilbert et al. · Immunity Open access Aug 2002 689
2 Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy Jonas C. S. Bergh, Torbjörn Norberg, Sigrid Sjögren et al. · Nature Medicine Oct 1995 464
3 Clinical utility of cytokeratins as tumor markers Vivian Barak, Helena M. Goike, Katja W. Panaretakis et al. · Clinical Biochemistry Jul 2004 386
4 Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides Per Björk, Anders Björk, Thomas Vogl et al. · PLoS Biology Open access 16 Apr 2009 365
5 Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations Rafael Molina, Vivian Barak, Arie van Dalen et al. · Tumor Biology 2005 334
All 60 most cited papers, with filters and sorting

Which keywords describe research at Active Biotech (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Inflammation, Cancer Immunotherapy, Innate Immunity, Glycosylation, Immunity and Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation18▲ 4.3×33 topics
  2. Monoclonal Antibodies14▲ 56×3 topics
  3. Therapeutic Antibodies14▲ 61×2 topics
  4. Cancer Immunotherapy12▲ 49×2 topics
  5. Innate Immunity12▲ 19×8 topics
  6. Cancer12▲ 4.8×26 topics
  7. Glycosylation12▲ 30×3 topics
  8. Immunity10▲ 17×4 topics
  9. Immunotherapy9▲ 7.9×11 topics
  10. Antigen Presentation8▲ 48×2 topics
  11. Dendritic Cells8▲ 41×2 topics
  12. Tumor Antigen8▲ 57×1 topic
  13. Vaccine Adjuvants8▲ 57×1 topic
  14. Antibody Engineering8▲ 43×1 topic
  15. Fc Receptors8▲ 43×1 topic
  16. Biopharmaceuticals7▲ 57×3 topics
  17. Immunogenicity7▲ 74×2 topics
  18. Autoimmunity6▲ 18×4 topics
  19. Protein Aggregation6▲ 46×1 topic
  20. Recombinant Proteins6▲ 68×2 topics
  21. Stability6▲ 19×1 topic
  22. Cancer Therapy6▲ 5.7×13 topics
  23. NK Cell Recognition6▲ 31×1 topic
  24. Natural Killer Cells6▲ 31×1 topic
  25. Tumor Regression5▲ 35×2 topics
  26. Tumor Microenvironment5▲ 8.5×7 topics
  27. TGF-ß5▲ 17×4 topics
  28. Toll-like Receptors5▲ 17×4 topics
  29. Pathogen Recognition5▲ 32×2 topics
  30. Pattern Recognition Receptors5▲ 19×3 topics
  31. CD4+CD25+5▲ 36×1 topic
  32. Foxp35▲ 36×1 topic
  33. Liquid Chromatography5▲ 18×2 topics
  34. Angiogenesis5▲ 6.3×9 topics
  35. Chiral Separation5▲ 21×1 topic
  36. Cytokine-Mediated Link5▲ 38×1 topic
  37. Gas Chromatography5▲ 21×1 topic
  38. Innate Antiviral Responses5▲ 38×1 topic
  39. Metastasis4▲ 7.1×8 topics
  40. Lab-on-a-Chip4▲ 16×3 topics

Which research topics does Active Biotech (Sweden) publish most on?

By volume in 2022-now: Muon and positron interactions and applications, Galectins and Cancer Biology, Monoclonal and Polyclonal Antibodies Research and S100 Proteins and Annexins.

Muon and positron intera…1Muon and positron interactions and applications: 1 fractional worksGalectins and Cancer Bio…1Galectins and Cancer Biology: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksS100 Proteins and Annexins1S100 Proteins and Annexins: 1 fractional worksGlycosylation and Glycoproteins Research: 1 fractional worksNeonatal Respiratory Health Research: 1 fractional worksbiodegradable polymer sy…0biodegradable polymer synthesis and properties: 0 fractional worksLegal Systems and Judicial Processes: 0 fractional worksToxin Mechanisms and Immunotoxins: 0 fractional worksMultiple Myeloma Research and Treatments: 0 fractional works
Mechanics of MaterialsImmunologyRadiology, Nuclear Medicine and ImagingMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Muon and positron interactions and applications Mechanics of Materials 1 works
  2. 2 Galectins and Cancer Biology Immunology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 S100 Proteins and Annexins Molecular Biology 1 works
  5. 5 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  6. 6 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
  7. 7 biodegradable polymer synthesis and properties Biomaterials 0 works
  8. 8 Legal Systems and Judicial Processes Political Science and International Relations 0 works
  9. 9 Toxin Mechanisms and Immunotoxins Immunology 0 works
  10. 10 Multiple Myeloma Research and Treatments Hematology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.5%not open71.5%

World: 40% of research is openly available.

with international co-authors34.1%domestic only65.9%

World: 18% is written across borders.

How has Active Biotech (Sweden)'s research output changed?

Output in 2022-2025 was 23% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Active Biotech (Sweden) as a percentage of every work published that year, 0.000044% in 2024.

still counting0.0010%0.0020%Active Biotech (Sweden)0.00012% in 20251990200020102020

Fractional works of Active Biotech (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lund

All research institutions in Lund

Share Active Biotech (Sweden)'s ranking

Active Biotech (Sweden) on Science Explorer

A card with Active Biotech (Sweden)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Active Biotech (Sweden). Posts are plain text and can be reported.